ABSTRACT:
Stability of eye drop is Check by Various Parameter as Prescribe by Different Pharmacopeia as Well As various regulatory authorities, eye drops are subject to different Temperature & humidity for different time period, the regulatory authority like USFDA, TCA, EU, CDSCO.etc prescribe the time period & different Conditions in which eye has to be put, Stability test for eye drop has gain importance due to the fact that the sterile formulation is marketed & utilized in different continent & countries which has contrast Climate Conditions like North & South America has cold climate on other hand Africa & Middle East Has Humid Climate Hence to withstand such Climatic Conditions, The stability test Was carried out.
Cite this article:
Sarang Chavan, Dr. Gulam Javed Khan. A Brief Review on Stability testing of Eye Drop. IJRPAS, 2024; 3(1): 39-45.
1. Janoria
K. G.; Gunda S., Boddu S. H. S. and Mitra A. K., Novel approaches to retinal
drug delivery. Expert Opinion on Drug
Delivery, 2007; 13: 371-388.
2. Rathapon
Asasutjarit, Suthira Thanasanchokpibull, Asira Fuongfuchat, Sukitaya Veeranondha.,
Optimization and evaluation of thermoresponsive
diclofenac sodium ophthalmic in situ gels. International Journal of Pharmaceutics, 2011; 411: 128–135.
3. Annick
Ludwig, The use of mucoadhesive polymers in ocular drug delivery. Advanced Drug Delivery Reviews, 2005;
57(11): 1595-1639.
4. K.S.
Rathore, Insitu gelling ophthalmic drug delivery system: an overview. International Journal of Pharmacy and
Pharmaceutical Science, 2010; 2: 30-34.
5. Hughes
P. M.; Olejnik O., Chang-Lin J. E., Wilson C. G., Topical and systemic drug
delivery to the posterior segments. Advanced
Drug Delivery Review, 2005; 18: 2010-2032.
6. M Ahuja, AS Dhake, SK Sharma and DK
Majumdar, Topical ocular delivery of NSAIDs, The AAPS journal, 10(2), 2008,
229-241.
7. PT Peneva, Non-steroidal ant inflammatory
drugs for topical ophthalmic administration: contemporary trends, International
Journal of Pharmacy and Pharmaceutical Sciences, 7(9), 2015, 13-19.
8. IP Kaur, M Singh and M Kanwar, Formulation
and evaluation of ophthalmic preparations of acetazolamide, International
journal of pharmaceutics, 199(2), 2000, 119-127
9.
G. Hecht, R. E. Roehrs, J. C. Lang, D. P.
Rodheaver, and M. A. Chowhan, Design and evaluation of ophthalmic
pharmaceutical products, in Modern
Pharmaceutics, 3rd ed. (G. S. Banker and C. T. Rhodes, Eds.),
Marcel Dekker, New York, 1996, pp. 489–546
10. ICH
draft consensus guideline, Stability testing of new drug substances and
products, released at Step 2 of theICH process on October 7, 1999, by the ICH
Steering Committee. Available on line at: http:/
/www.ifpma.org/ich5q.html
11. Guidance for
Industry, Stability Testing of Drug Substances and Drug Products,
FDA Draft (not for implementation). Available on line at: http:/ /www.fda.gov/
cder/guidance/index.htm
12.
CPMP/QWP/556/96, Note for Guidance on Stability Testing of Existing Active Substances
and Related Finished Products. Available on line at: http:/ /www.
eudra.org/humandocs/humans/QWP.htm
13. U.S.
Pharmacopeial Convention, United
States Pharmacopeia, 23rd ed., Author, Rockville, MD, 1994.
14. Society
of Japanese Pharmacopoeia, The
Japanese Pharmacopoeia, 13th ed., distributed by Yakuji Nippo,
KandaIzumicho, Chiyodoku, Tokyo, 1996
15. Drug Approval and Licensing Procedures in Japan
1994,Yakugyo
Jiho, Kanda Jimbo-cho, Chiyoda-ku, Tokyo,1995, pp. 134–139.
16.
Japanese
Stability Testing Guidelines Incorporating ICH Guidelines,
Yakushinyaku No. 30, Osaka Medications Association, Chuo-ku, Osaka-shi, April
21, 1994.
17.
ICH draft consensus guideline, Stability
testing of new drug substances and products, released at Step 2 of the ICH
process on October 7, 1999, by the ICH Steering Committee. Available on line
at: http:/ /www.ifpma.org/
ich5q.html
18. Guidance for
Industry, Stability Testing of Drug Substances and Drug Products,
FDA Draft (not for implementation). Available on line at: http:/ /stability testing of eye
drop.docx
19. Society
of Japanese Pharmacopoeia, The
Japanese Pharmacopoeia, 13th ed., distributed by Yakuji Nippo, Kanda
Izumicho, Chiyodoku, Tokyo, 1996.
20. Food
Drug and Administration. Guidance for Industry: Drug Stability Guidelines.
Available online: https://www.fda.gov/
media/69957/download (accessed on 20 October 2020).
21. European
Medicines Agency. ICH Topic Q1A(R2): Stability Testing of New Drug Substances
and Products.Availablehttps://www.ema.europa.eu/en/documents/scientific-guideline/ich-q-1-r2-stability-testing-new-drug-substancesproducts-
step-5_en.pdf (accessed on 20 October 2020).
22. EDQM
(European Directorate for the Quality of Medicines & Healthcare). European
Pharmacopoeia 10.5; 2020, 5.1.4 Sterility Assay 04/2011:20601; EDQM Council of
Europe: Strasbourg, France, 2020